```html
<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8" />
  <title>PromptGenix – Research Strategy (Approach, Phase I)</title>
  <meta name="viewport" content="width=device-width, initial-scale=1" />
  <meta name="description" content="PromptGenix SBIR Phase I Approach: evidence-weighted hypothesis prioritization workflow, validation plan, milestones, KPIs, and risks & mitigation."/>

  <style>
    * { box-sizing: border-box; }
    body{
      margin:0;
      font-family:-apple-system,BlinkMacSystemFont,"Segoe UI",sans-serif;
      background:#020617;
      color:#e5e7eb;
      line-height:1.5;
    }
    a{ color:inherit; text-decoration:none; }
    .page{ min-height:100vh; display:flex; flex-direction:column; }

    header{
      position:sticky; top:0; z-index:30;
      backdrop-filter: blur(14px);
      background: rgba(15, 23, 42, 0.92);
      border-bottom: 1px solid rgba(148, 163, 184, 0.3);
    }
    .nav{
      max-width:1120px; margin:0 auto; padding:14px 20px;
      display:flex; align-items:center; justify-content:space-between; gap:18px;
    }
    .nav-left{ display:flex; align-items:center; gap:12px; }
    .logo-dot{
      width:28px; height:28px; border-radius:999px;
      background: radial-gradient(circle at 0 0,#38bdf8,#8b5cf6);
      box-shadow:0 0 18px rgba(56,189,248,.7);
    }
    .brand{ font-size:1.1rem; font-weight:650; letter-spacing:.04em; }
    .subbrand{ font-size:.72rem; color:#9ca3af; margin-top:2px; }

    .nav-links{ display:flex; gap:10px; flex-wrap:wrap; justify-content:flex-end; }
    .nav-links a{
      font-size:.88rem; color:#9ca3af;
      padding:6px 10px; border-radius:999px;
      border:1px solid rgba(148,163,184,0.18);
      background: rgba(2,6,23,0.25);
    }
    .nav-links a:hover{
      color:#e5e7eb;
      background: rgba(148,163,184,0.18);
      border-color: rgba(148,163,184,0.35);
    }
    .nav-links a.active{
      color:#e5e7eb;
      background: rgba(148,163,184,0.18);
      border-color: rgba(148,163,184,0.55);
    }

    main{ flex:1; }

    .section{
      max-width: 1120px;
      margin: 0 auto;
      padding: 28px 20px;
    }

    .topline{
      display:flex; flex-wrap:wrap; gap:10px;
      align-items:flex-end; justify-content:space-between;
      padding-top: 16px;
      margin-bottom: 14px;
    }
    .doc-title{
      font-size: 1.35rem;
      font-weight: 820;
      color:#f9fafb;
      margin: 0;
    }
    .meta{
      font-size:.78rem;
      color:#9ca3af;
    }

    .kicker{
      font-size: .78rem;
      text-transform: uppercase;
      letter-spacing: .18em;
      color: #a5b4fc;
      margin-bottom: 6px;
    }

    h2{
      font-size: 1.15rem;
      font-weight: 760;
      color:#f9fafb;
      margin: 14px 0 8px;
    }

    p{
      margin: 0 0 10px;
      font-size: .95rem;
      color:#d1d5db;
    }

    .grid-2{
      display:grid;
      grid-template-columns: minmax(0,1.1fr) minmax(0,1fr);
      gap:18px;
      margin-top: 10px;
      align-items:start;
    }

    .card{
      border-radius: 16px;
      padding: 14px 16px;
      background: rgba(15,23,42,0.84);
      border: 1px solid rgba(148,163,184,0.28);
      box-shadow: 0 18px 45px rgba(15,23,42,0.55);
    }

    .card h3{
      margin: 0 0 8px;
      font-size: .95rem;
      letter-spacing: .14em;
      text-transform: uppercase;
      color:#a5b4fc;
    }

    ul{
      margin: 6px 0 0;
      padding-left: 1.1rem;
      color:#d1d5db;
      font-size: .94rem;
    }
    li{ margin-bottom: 6px; }
    li strong{ color:#e5e7eb; }

    .pill-row{ display:flex; flex-wrap:wrap; gap:8px; margin-top:10px; }
    .pill{
      font-size:.74rem;
      padding: 5px 9px;
      border-radius: 999px;
      border: 1px solid rgba(129,140,248,0.45);
      background: rgba(2,6,23,0.25);
      color:#c7d2fe;
    }

    .callout{
      border-radius: 14px;
      padding: 12px 14px;
      border: 1px dashed rgba(148,163,184,0.5);
      background: rgba(15,23,42,0.75);
      font-size: .92rem;
      color:#e5e7eb;
      margin-top: 12px;
    }
    .callout strong{ color:#22c55e; }

    /* Table */
    .table{
      width:100%;
      border-collapse: collapse;
      margin-top: 10px;
      overflow:hidden;
      border-radius: 14px;
      border: 1px solid rgba(148,163,184,0.28);
      background: rgba(15,23,42,0.6);
    }
    .table th, .table td{
      padding: 12px 12px;
      border-bottom: 1px solid rgba(148,163,184,0.18);
      vertical-align: top;
      font-size: .95rem;
      color:#e5e7eb;
    }
    .table th{
      font-size: .82rem;
      text-transform: uppercase;
      letter-spacing: .14em;
      color:#a5b4fc;
      background: rgba(2,6,23,0.35);
    }

    footer{
      border-top:1px solid rgba(31,41,55,0.9);
      padding:16px;
      font-size:.78rem;
      color:#6b7280;
      text-align:center;
    }

    @media (max-width: 920px){
      .grid-2{ grid-template-columns: minmax(0,1fr); }
    }

    /* Figure styles */
    .pgx-figure{ margin: 0; }
    .pgx-figure figcaption{
      margin: 10px 0 10px;
      font-size: 13.5px;
      color: #e5e7eb;
    }
    .pgx-figure-panel{
      background: #f1f5f9;
      border-radius: 14px;
      padding: 14px 14px;
      border: 1px solid rgba(15,23,42,0.25);
      box-shadow: 0 10px 28px rgba(0,0,0,0.35);
      overflow:hidden;
    }
    .pgx-figure-panel svg{
      display:block;
      width:100%;
      height:auto;
    }
    .pgx-figure-panel svg .box{
      fill:#f8fafc;
      stroke:#0f172a;
      stroke-width:2;
    }
    .pgx-figure-panel svg .box-soft{
      fill:#e2e8f0;
      stroke:#0f172a;
      stroke-width:2;
    }
    .pgx-figure-panel svg .arrow{
      stroke:#0f172a;
      stroke-width:2.2;
    }
    .pgx-figure-panel svg marker path{ fill:#0f172a; }
    .pgx-figure-panel svg text{ fill:#0b1220; }

    /* Print */
    @media print {
      header, footer { display: none !important; }
      body { background:#fff !important; color:#111 !important; }
      p, li { color:#111 !important; }
      h1, h2, h3 { color:#111 !important; }
      * { box-shadow: none !important; }
      @page { size: Letter; margin: 0.5in; }
      .section { max-width: 100% !important; padding: 0 !important; }
      .pgx-figure figcaption { color:#111 !important; }
      .pgx-figure-panel{
        background:#fff !important;
        border: 1px solid #111 !important;
      }
    }
  </style>
</head>

<body>
<div class="page">
  <header>
    <div class="nav">
      <div class="nav-left">
        <div class="logo-dot"></div>
        <div>
          <div class="brand">PromptGenix</div>
          <div class="subbrand">SBIR Portal</div>
        </div>
      </div>
      <nav class="nav-links">
        <!-- NAV: full set, consistent across pages -->
        <a href="index.html">Portal</a>
        <a href="sbir.html">SBIR</a>
        <a href="aims.html">Aims</a>
        <a href="approach.html" class="active">Approach</a>
        <a href="commercialization.html">Commercialization</a>
        <a href="facilities.html">Facilities</a>
        <a href="team.html">Team</a>
        <a href="use-cases.html">Use Cases</a>
      </nav>
    </div>
  </header>

  <main>
    <section class="section">
      <div class="topline">
        <h1 class="doc-title">Research Strategy – Approach (Phase I Workflow &amp; Validation)</h1>
        <div class="meta">
          PromptGenix LLC &middot; Contact: dohoon.kim1@icloud.com &middot; promptgenix.org
        </div>
      </div>

      <div class="kicker">Phase I goal</div>
      <h2>Build a validated prototype that prioritizes testable biological hypotheses using evidence-weighted inference over public data and literature.</h2>
      <p>
        Phase I focuses on engineering robustness, reproducibility, and measurable scientific utility for a
        <strong>hypothesis intelligence engine</strong>.
        Validation will rely exclusively on public sources (e.g., GEO/SRA, FlowRepository, and PubMed/PMC),
        minimizing IP or data-use conflicts while enabling transparent evaluation.
      </p>
      <p>
        In this project, analysis pipelines are treated as <strong>evidence generators</strong>—not the end product.
        The primary Phase I deliverable is a system that produces <strong>ranked hypotheses with probabilistic confidence</strong>,
        explicit evidence links, and clear uncertainty labeling.
      </p>

      <div class="grid-2">
        <div class="card">
          <h3>Workflow overview</h3>
          <ul>
            <li><strong>Inputs:</strong> Disease-, protein-, pathway-, or cell-type–centric questions, optionally linked to public accession IDs.</li>
            <li><strong>Evidence pool:</strong> automated retrieval of relevant public datasets + associated metadata + literature signals.</li>
            <li><strong>Evidence generation:</strong> standardized feature extraction (effect sizes, uncertainty, reproducibility, context descriptors).</li>
            <li><strong>Decision engine:</strong> statistical scoring + Bayesian updating to compute confidence distributions for candidate hypotheses.</li>
            <li><strong>Interpretability layer:</strong> LLM produces explanations constrained by evidence objects (no evidence → no claim).</li>
            <li><strong>Outputs:</strong> ranked hypotheses + confidence bands + “why” rationale + recommended follow-up experiments.</li>
          </ul>
          <div class="pill-row">
            <span class="pill">Evidence objects</span>
            <span class="pill">Bayesian updating</span>
            <span class="pill">Uncertainty labels</span>
            <span class="pill">Traceable outputs</span>
          </div>
        </div>

        <div class="card">
          <h3>Hypothesis Prioritization Engine (traceable)</h3>
          <p>
            PromptGenix prioritizes <strong>testable hypotheses</strong> by combining quantitative evidence with structured biological priors.
            Large language models are used <strong>only</strong> to contextualize and explain rankings—not to determine them.
          </p>
          <ul>
            <li><strong>Candidate hypothesis set:</strong> generated from structured entities (disease/protein/cell-type) and literature-derived relations.</li>
            <li><strong>Evidence strength:</strong> effect size + uncertainty + directionality + reproducibility across datasets/contexts.</li>
            <li><strong>Bayesian confidence:</strong> priors (known biology, pathways, cell specificity) updated by observed evidence to yield posteriors.</li>
            <li><strong>Ranking outputs:</strong> posterior mean + credible interval + evidence coverage (supporting vs. conflicting).</li>
            <li><strong>Actionability:</strong> each hypothesis includes suggested next-step experiments/analyses and required data.</li>
          </ul>
          <div class="callout">
            <strong>Phase I emphasis:</strong> transparent ranking with uncertainty, not “black-box” generation.
          </div>
        </div>
      </div>

      <!-- FULL-WIDTH FIGURE (DIAGRAM INCLUDED) -->
      <div class="card" style="margin-top:18px;">
        <h3>Bayesian Evidence-to-Confidence Workflow (Figure X)</h3>

        <figure class="pgx-figure">
          <figcaption><strong>Figure X.</strong> Stepwise workflow of the PromptGenix decision engine, from query intake to evidence extraction, Bayesian updating, confidence scoring, and evidence-constrained interpretation.</figcaption>

          <div class="pgx-figure-panel">
            <svg viewBox="0 0 1420 420" xmlns="http://www.w3.org/2000/svg" role="img" aria-label="Bayesian Evidence-to-Confidence Flow (Two-row tidy)">
              <defs>
                <marker id="arrow" markerWidth="12" markerHeight="12" refX="10" refY="6" orient="auto">
                  <path d="M0,0 L12,6 L0,12 Z"></path>
                </marker>
              </defs>

              <!-- TOP ROW -->
              <g font-family="Arial, sans-serif" font-size="18">
                <rect class="box" x="70" y="50" width="240" height="92" rx="12"></rect>
                <text x="190" y="82" text-anchor="middle" font-weight="800">User Query</text>
                <text x="190" y="108" text-anchor="middle" font-size="15">(disease / protein</text>
                <text x="190" y="128" text-anchor="middle" font-size="15">/ cell-type)</text>

                <line class="arrow" x1="310" y1="96" x2="360" y2="96" marker-end="url(#arrow)"></line>

                <rect class="box" x="360" y="50" width="260" height="92" rx="12"></rect>
                <text x="490" y="82" text-anchor="middle" font-weight="800">(1) Retrieval</text>
                <text x="490" y="108" text-anchor="middle" font-size="15">Public datasets + literature</text>

                <line class="arrow" x1="620" y1="96" x2="670" y2="96" marker-end="url(#arrow)"></line>

                <rect class="box" x="670" y="50" width="290" height="92" rx="12"></rect>
                <text x="815" y="82" text-anchor="middle" font-weight="800">(2) Harmonization</text>
                <text x="815" y="108" text-anchor="middle" font-size="15">Metadata normalization</text>
                <text x="815" y="128" text-anchor="middle" font-size="15">QC + batch/study modeling</text>

                <line class="arrow" x1="960" y1="96" x2="1010" y2="96" marker-end="url(#arrow)"></line>

                <rect class="box" x="1010" y="50" width="320" height="92" rx="12"></rect>
                <text x="1170" y="82" text-anchor="middle" font-weight="800">(3) Hypotheses</text>
                <text x="1170" y="108" text-anchor="middle" font-size="15">Structured templates</text>
                <text x="1170" y="128" text-anchor="middle" font-size="15">(testable statements)</text>
              </g>

              <!-- Connector: 3 -> 4 -->
              <path class="arrow" d="M1170 142 V190 H250 V225" fill="none" marker-end="url(#arrow)"></path>

              <!-- BOTTOM ROW -->
              <g font-family="Arial, sans-serif" font-size="18">
                <rect class="box" x="70" y="225" width="360" height="92" rx="12"></rect>
                <text x="250" y="257" text-anchor="middle" font-weight="800">(4) Evidence Extraction</text>
                <text x="250" y="283" text-anchor="middle" font-size="15">Effect sizes + uncertainty</text>
                <text x="250" y="303" text-anchor="middle" font-size="15">quality weights + directionality</text>

                <line class="arrow" x1="430" y1="271" x2="480" y2="271" marker-end="url(#arrow)"></line>

                <rect class="box-soft" x="480" y="225" width="340" height="92" rx="12"></rect>
                <text x="650" y="257" text-anchor="middle" font-weight="900">(5) Bayesian Update</text>
                <text x="650" y="283" text-anchor="middle" font-size="15">Prior P(H) × Likelihood P(E|H)</text>
                <text x="650" y="303" text-anchor="middle" font-size="15">→ Posterior P(H|E)</text>

                <line class="arrow" x1="820" y1="271" x2="870" y2="271" marker-end="url(#arrow)"></line>

                <rect class="box" x="870" y="225" width="250" height="92" rx="12"></rect>
                <text x="995" y="257" text-anchor="middle" font-weight="800">(6) Confidence</text>
                <text x="995" y="283" text-anchor="middle" font-size="15">Posterior mean/median</text>
                <text x="995" y="303" text-anchor="middle" font-size="15">+ 95% CrI + robustness</text>

                <line class="arrow" x1="1120" y1="271" x2="1160" y2="271" marker-end="url(#arrow)"></line>

                <rect class="box" x="1150" y="225" width="260" height="92" rx="12"></rect>
                <text x="1280" y="257" text-anchor="middle" font-weight="800">(7) Interpretability</text>
                <text x="1280" y="283" text-anchor="middle" font-size="15">LLM rationale constrained</text>
                <text x="1280" y="303" text-anchor="middle" font-size="15">to evidence + next steps</text>
              </g>
            </svg>
          </div>
        </figure>
      </div>

      <div class="kicker" style="margin-top:18px;">How confidence is computed</div>
      <h2>Probabilistic confidence is derived from evidence features and Bayesian updating.</h2>
      <div class="callout">
        <strong>Conceptual model:</strong>
        For each hypothesis <em>H</em>, we define a prior probability <em>P(H)</em> from structured biological knowledge (literature, pathways, cell specificity).
        We then compute evidence likelihood <em>P(E|H)</em> from standardized evidence features (effect size, uncertainty, reproducibility, context).
        The system produces a posterior confidence <em>P(H|E)</em>, reported with a credible interval and explicit evidence coverage.
      </div>

      <div class="kicker" style="margin-top:18px;">Phase I validation plan</div>
      <h2>Public-data evaluation with measurable KPIs.</h2>

      <table class="table" aria-label="Phase I validation plan table">
        <thead>
          <tr>
            <th style="width:18%;">Work package</th>
            <th style="width:52%;">What we will do</th>
            <th style="width:30%;">Success metrics (examples)</th>
          </tr>
        </thead>
        <tbody>
          <tr>
            <td><strong>WP1</strong><br/>Evidence layer</td>
            <td>
              Build a robust ingest + evidence feature extraction layer for selected public datasets.
              Generate standardized evidence objects (effect sizes, uncertainty, reproducibility, and context descriptors)
              suitable for deterministic re-runs and downstream inference.
            </td>
            <td>
              ≥90% reproducibility across reruns (same inputs/configs).<br/>
              Evidence objects produced for ≥80% of targeted datasets despite heterogeneity.
            </td>
          </tr>
          <tr>
            <td><strong>WP2</strong><br/>Decision engine</td>
            <td>
              Implement statistical scoring and Bayesian updating to compute posterior confidence distributions for candidate hypotheses.
              Produce ranked outputs with uncertainty annotations and explicit supporting vs. conflicting evidence summaries.
            </td>
            <td>
              Calibrated confidence outputs (posterior intervals behave as expected in held-out tests).<br/>
              Clear traceability: each ranked hypothesis links to evidence objects + citations.
            </td>
          </tr>
          <tr>
            <td><strong>WP3</strong><br/>Interpretability &amp; reports</td>
            <td>
              Generate reviewer-ready HTML/PDF artifacts that include: ranked hypotheses, confidence bands, evidence coverage,
              citations, and recommended next steps. LLM narratives are constrained to evidence objects and must cite sources.
            </td>
            <td>
              End-to-end run completes within &lt;24 hours from accession-driven inputs (dataset-dependent).<br/>
              ≥80% “useful” rating by pilot users (guides at least one concrete experimental/analysis decision).
            </td>
          </tr>
        </tbody>
      </table>

      <div class="callout">
        <strong>Data-use boundary:</strong> Phase I evaluation uses public datasets only (GEO/SRA/FlowRepository) and public literature sources,
        enabling clean SBIR review and minimizing IP concerns.
      </div>

      <div class="kicker" style="margin-top:18px;">Risks &amp; Mitigation</div>
      <h2>Practical risks addressed with explicit fallback strategies.</h2>

      <div class="grid-2">
        <div class="card">
          <h3>Technical risks</h3>
          <ul>
            <li><strong>Dataset heterogeneity:</strong> inconsistent metadata, formats, and cohort contexts across repositories.</li>
            <li><strong>Evidence sparsity:</strong> some hypotheses may lack sufficient supporting data or have conflicting signals.</li>
            <li><strong>Compute variability:</strong> differences between local and cloud environments affecting deterministic reruns.</li>
            <li><strong>LLM overreach:</strong> narrative may overstate conclusions without strict constraints.</li>
          </ul>
        </div>

        <div class="card">
          <h3>Mitigation strategies</h3>
          <ul>
            <li><strong>Robust ingest:</strong> schema detection + validation + standardized evidence templates and QC gates.</li>
            <li><strong>Evidence coverage labeling:</strong> explicit “supporting vs. conflicting vs. missing” flags per hypothesis.</li>
            <li><strong>Deterministic runs:</strong> pinned versions, config snapshots, and checksums for reproducibility.</li>
            <li><strong>Traceability guardrails:</strong> LLM can only reference approved evidence objects; no evidence → no claim.</li>
            <li><strong>Fallback mode:</strong> if evidence is weak, output “candidate hypotheses” with low-confidence tags and data-needed guidance.</li>
          </ul>
        </div>
      </div>

      <div class="callout">
        <strong>Reviewer-friendly principle:</strong> Every claim must be traceable to (1) evidence objects derived from public data or (2) cited literature,
        with uncertainty explicitly stated.
      </div>

      <div class="callout">
        <strong>Phase I success criterion:</strong> Phase I does not require all prioritized hypotheses to be biologically correct,
        but rather demonstrable traceability, calibrated uncertainty, transparent ranking rationale, and usefulness for guiding study design decisions.
      </div>

    </section>
  </main>

  <footer>
    PromptGenix &middot; SBIR Portal &middot;
    <a href="mailto:dohoon.kim1@icloud.com">dohoon.kim1@icloud.com</a>
  </footer>
</div>
</body>
</html>
```
